Cargando…
Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer
Oncolytic virotherapy is an encouraging treatment using herpes simplex virus (HSV) for gastric cancer patients. To treat gastric cancer, we generated and evaluated the efficacy of an attractive type of oncolytic HSV expressing the suppressor of cytokine signaling 3 (SOCS3). We constructed a third-ge...
Autores principales: | Matsumura, Shuichi, Nakamori, Mikihito, Tsuji, Toshiaki, Kato, Tomoya, Nakamura, Masaki, Ojima, Toshiyasu, Fukuhara, Hiroshi, Ino, Yasushi, Todo, Tomoki, Yamaue, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899552/ https://www.ncbi.nlm.nih.gov/pubmed/33659045 http://dx.doi.org/10.18632/oncotarget.27873 |
Ejemplares similares
-
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
por: Kato, Tomoya, et al.
Publicado: (2021) -
Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer
por: Kato, Tomoya, et al.
Publicado: (2021) -
Oncolytic virus therapy: A new era of cancer treatment at dawn
por: Fukuhara, Hiroshi, et al.
Publicado: (2016) -
Endoscopic treatment of esophageal fistulas after esophagectomy with injection of an alpha-cyanoacrylate monomer: a phase II study
por: Ojima, Toshiyasu, et al.
Publicado: (2018) -
Triangulating stapling vs functional end-to-end stapling for cervical esophagogastric anastomosis after esophagectomy for thoracic esophageal cancer: study protocol for a randomized controlled trial
por: Tsuji, Toshiaki, et al.
Publicado: (2019)